Roundtable Discussion: Analyzing Emerging Biomarker Targets to Evaluate Treatment Efficacy & Advance Safety & Patient Access Through Personalized Medicines
Time: 11:30 am
day: Conference Day Two Teal Track
Details:
- Evaluate CD-19 as a reliable target to track B-cell depletion and monitor treatment response
- Leverage CD-19 tracking to enhance individualized diagnostic and therapeutic strategies in autoimmune diseases
- Explore the development of novel autoimmune-specific biomarkers to enable personalized medicine approaches, inspired by successes in oncology
